| answer text |
<p> </p><p>Cancer survival and mortality rates continue to improve although it is
too early to assess progress against our ambition to save an additional 5,000 lives
per year by 2014-15, to halve the gap between the survival estimates in England and
those in the best countries in Europe. Proxy measures are being developed to enable
an assessment of progress in a more timely manner, particularly in terms of the proportion
of cancers diagnosed at stages one and two and cancers diagnosed through emergency
routes.</p><p> </p><p> </p><p> </p><p>The National Health Service and Public Health
Outcomes Framework indicators and the Clinical Commissioning Group (CCG) Outcomes
Indicator Set are starting to enable us to assess progress, at national and local
level. For example, data on one-year survival from all cancers and one-year survival
from breast, lung and colorectal cancer were published as part of the CCG outcomes
indicator set for the first time on 19 June 2014. NHS England is continuing to monitor
the progress of the NHS in reducing mortality from cancer in line with the NHS Outcomes
Framework, and from 2014-15 there will be a range of new NHS Outcomes Framework indicators
reflecting different stages of diagnosis which will provide a good proxy measure in
future on progress in delivering earlier stage of diagnosis of cancer.</p><p> </p><p>
</p><p> </p><p>The Mandate for the NHS for 2014-15 sets out an ambition for England
to become one of the most successful countries in Europe at preventing premature deaths.
Tackling premature deaths from cancer will contribute to this. A range of work at
national and local level is aimed at improving cancer survival. For example, results
from the first national “Be Clear on Cancer” lung cancer campaign in 2012 showed that
around 700 extra patients were diagnosed with lung cancer compared to the previous
year. Approximately 400 of these patients had their lung cancer diagnosed at an early
stage, with around 300 more patients having surgery, giving them a better chance of
survival.</p><p> </p><p> </p><p> </p><p>NHS England took over responsibility for the
annual national cancer patient experience survey from April 2013. The survey results
are used by a range of stakeholders to identify practices that lead to positive experience
for patients, and promote improvements.</p><p> </p><p> </p><p> </p><p>NHS England
is working with NHS Improving Quality and other partners to develop more effective
ways of using the survey results within the NHS, for example, working with successful
and struggling organisations to identify and spread best practice.</p><p> </p><p>
</p><p> </p><p>CCGs are currently in the process of finalising measurable levels of
ambition to improve patient experience and will be holding providers to account. These
are based on NHS England's new measure for poor inpatient experience which includes
whether patients are treated with dignity and respect.</p><p> </p><p> </p><p> </p><p>Compassion
in Practice, the three year vision and strategy for nursing, midwifery and care staff,
is also seeking to increase feedback from vulnerable and disadvantaged patient groups,
who can have poorer experiences of care.</p><p> </p><p> </p><p> </p><p>In April 2014,
NHS England introduced the staff friends and family test for all NHS Trusts in England,
as research shows the strong link between levels of staff engagement and quality of
patient experience.</p><p> </p>
|
|
